ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025
ProPhase Labs (NASDAQ:PRPH), a biotech, genomics and consumer products company, has scheduled its second quarter 2025 financial results presentation for August 13, 2025, at 2:00 pm EDT. The company will host a virtual conference call through Renmark Financial, with financial results to be released via press release before the call.
Stakeholders and investors can attend the live event by registering through Renmark Financial's platform. A replay of the presentation will be made available on ProPhase's investor website after the event.
ProPhase Labs (NASDAQ:PRPH), una societ脿 di biotecnologia, genomica e prodotti di consumo, ha programmato la presentazione dei risultati finanziari del secondo trimestre 2025 per il 13 agosto 2025 alle 14:00 EDT. La societ脿 terr脿 una conference call virtuale tramite Renmark Financial; i risultati saranno diffusi in un comunicato stampa prima della chiamata.
I portatori di interesse e gli investitori possono partecipare all'evento in diretta registrandosi tramite la piattaforma di Renmark Financial. Una registrazione della presentazione sar脿 disponibile sul sito per gli investitori di ProPhase dopo l'evento.
ProPhase Labs (NASDAQ:PRPH), una empresa de biotecnolog铆a, gen贸mica y productos de consumo, ha programado la presentaci贸n de resultados financieros del segundo trimestre de 2025 para el 13 de agosto de 2025 a las 14:00 EDT. La compa帽铆a realizar谩 una conferencia telef贸nica virtual a trav茅s de Renmark Financial; los resultados se difundir谩n mediante un comunicado de prensa antes de la llamada.
Las partes interesadas e inversores pueden asistir al evento en directo registr谩ndose a trav茅s de la plataforma de Renmark Financial. Una grabaci贸n de la presentaci贸n estar谩 disponible en la web de inversores de ProPhase despu茅s del evento.
ProPhase Labs (NASDAQ:PRPH)電� 氚旍澊鞓ろ厡韥缝湢鞝勳泊頃櫬缝唽牍勳灛 旮办梾鞙茧, 2025雲� 2攵勱赴 鞁れ爜 氚滍憸鞚� 2025雲� 8鞗� 13鞚� 鞓ろ泟 2鞁�(EDT)鞐� 臧滌禍頃� 鞓堨爼鞛呺媹雼�. 須岇偓電� Renmark Financial鞚� 韱淀暣 臧�靸� 旎嵓霟办姢 旖滌潉 歆勴枆頃橂┌, 鞛鞁れ爜鞚� 旖� 鞝勳棎 氤措弰鞛愲搿� 氚滍憸霅╇媹雼�.
鞚错暣甏�瓿勳瀽 氚� 韴瀽鞛愲姅 Renmark Financial 頂岆灚韽检潉 韱淀暣 霌彪頃橂┐ 鞁れ嫓臧勳溂搿� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 氚滍憸 雲鬼檾電� 頄夓偓 頉� ProPhase鞚� 韴瀽鞛� 鞗轨偓鞚错姼鞐� 瓴岇嫓霅� 鞓堨爼鞛呺媹雼�.
ProPhase Labs (NASDAQ:PRPH), une soci茅t茅 de biotechnologie, de g茅nomique et de produits grand public, a programm茅 la pr茅sentation des r茅sultats financiers du deuxi猫me trimestre 2025 pour le 13 ao没t 2025 脿 14h00 (EDT). La soci茅t茅 organisera une conf茅rence t茅l茅phonique virtuelle via Renmark Financial ; les r茅sultats seront publi茅s dans un communiqu茅 de presse avant l'appel.
Les parties prenantes et les investisseurs peuvent assister 脿 l'茅v茅nement en direct en s'inscrivant via la plateforme de Renmark Financial. Une rediffusion de la pr茅sentation sera mise en ligne sur le site investisseurs de ProPhase apr猫s l'茅v茅nement.
ProPhase Labs (NASDAQ:PRPH), ein Unternehmen f眉r Biotechnologie, Genomik und Konsumg眉ter, hat die Pr盲sentation der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r den 13. August 2025 um 14:00 Uhr EDT angesetzt. Das Unternehmen wird eine virtuelle Telefonkonferenz 眉ber Renmark Financial abhalten; die Ergebnisse werden vor dem Anruf per Pressemitteilung ver枚ffentlicht.
Interessengruppen und Investoren k枚nnen an der Live-Veranstaltung teilnehmen, indem sie sich 眉ber die Plattform von Renmark Financial registrieren. Ein Replay der Pr盲sentation wird nach der Veranstaltung auf der Investorenseite von ProPhase verf眉gbar sein.
- None.
- None.
UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the 鈥淐ompany鈥� or 鈥淧roPhase鈥�), a next generation biotech, genomics and consumer products company, announced today that they will be presenting second quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on August 13, 2025, at 2:00 pm EDT.
A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event.
Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company鈥檚 investor website.
REGISTER HERE:
- To ensure smooth connectivity, please access this link using the latest version of Google Chrome.
About ProPhase Labs Inc.
ProPhase Labs Inc. (Nasdaq: PRPH) (鈥淧roPhase鈥�) is a next-generation biotech, genomics and consumer products company. Our mission is to build a healthier world through bold innovation and actionable insight. We鈥檙e revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, groundbreaking diagnostic development 鈥� such as our potentially life-saving test for the early detection of esophageal cancer 鈥� and a world class direct-to-consumer marketing platform for cutting edge OTC dietary supplements. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs鈥� valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value.聽
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
Retail Investor Relations Contact:
Renmark Financial Communications Inc.
John Boidman:聽
Tel.: (416) 644-2020 or (212) 812-7680
FAQ
When will ProPhase Labs (PRPH) release Q2 2025 earnings?
How can investors access ProPhase Labs' Q2 2025 earnings call?
What will ProPhase Labs discuss in their Q2 2025 earnings call?
What browser should I use to access ProPhase Labs' Q2 earnings call?
